IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4.
Mingli NiBeibei QinLing XieXudong ZhangJiezhi YangHongqiong LvMingyue YangMing-Zhi ZhangPublished in: BioMed research international (2018)
Our findings concluded that IL-13 inhibited chemotherapy sensitivity of NK/T-cell lymphoma cells by regulating ABCC4, disrupting which may effectively improve the therapy protocols against resistant NK/T-cell lymphoma.